Rare NRXN1 promoter variants in patients with schizophrenia

Neuroscience Letters

Volumn 475, Issue 2, 2010, Pages 80-84

  Shah, Abhishek K ^a   Tioleco, Nina M ^a   Nolan, Karen ^b,c   Locker, Joseph ^a   Groh, Katherine ^a   Villa, Catalina ^a   Stopkova, Pavla ^d   Pedrosa, Erika ^a   Lachman, Herbert M ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

Author keywords

Autism; Bipolar disorder; CNV; Copy variant; Neurexin; Schizophrenia

Indexed keywords

GENE PRODUCT; PROTEIN NRXN1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; EXON; FEMALE; GENE DELETION; GENE FUNCTION; GENE TARGETING; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; POINT MUTATION; POPULATION RESEARCH; PRIORITY JOURNAL; PROMOTER REGION; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BASE SEQUENCE; BINDING SITES; CELL ADHESION MOLECULES, NEURONAL; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; POINT MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; SCHIZOPHRENIA;

EID: 77952885725     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.03.047     Document Type: Article

References (30)

1. Benes F.M., Lim B., Matzilevich D., Walsh J.P., Subburaju S., Minns M. Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars. Proc. Natl. Acad. Sci. U.S.A. 2007, 104(24):10164-10169.
2. Bierut L.J., Madden P.A., Breslau N., Johnson E.O., Hatsukami D., Pomerleau O.F., Swan G.E., Rutter J., Bertelsen S., Fox L., Fugman D., Goate A.M., Hinrichs A.L., Konvicka K., Martin N.G., Montgomery G.W., Saccone N.L., Saccone S.F., Wang J.C., Chase G.A., Rice J.P., Ballinger D.G. Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum. Mol. Genet. 2007, 16(1):24-35.
3. Bowden N.A., Weidenhofer J., Scott R.J., Schall U., Todd J., Michie P.T., Tooney P.A. Preliminary investigation of gene expression profiles in peripheral blood lymphocytes in schizophrenia. Schizophr. Res. 2006, 82(2-3):175-183.
4. Bucan M., Abrahams B.S., Wang K., Glessner J.T., Herman E.I., Sonnenblick L.I., Alvarez- Retuerto A.I., Imielinski M., Hadley D., Bradfield J.P., Kim C., Gidaya N.B., Lindquist I., Hutman T., Sigman M., Kustanovich V., Lajonchere C.M., Singleton A., Kim J., Wassink T.H., McMahon W.M., Owley T., Sweeney J.A., Coon H., Nurnberger J.I., Li M., Cantor R.M., Minshew N.J., Sutcliffe J.S., Cook E.H., Dawson G., Buxbaum J.D., Grant S.F., Schellenberg G.D., Geschwind D.H., Hakonarson H. Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes. PLoS Genet. 2009, 5(6):e1000536.
5. Choi W.I., Jeon B.N., Park H., Yoo J.Y., Kim Y.S., Koh D.I., Kim M.H., Kim Y.R., Lee C.E., Kim K.S., Osborne T.F., Hur M.W. Proto-oncogene FBI-1 (Pokemon) and SREBP-1 synergistically activate transcription of fatty-acid synthase gene (FASN). J. Biol. Chem. 2008, 283(43):29341-29354.
6. Dudanova I., Tabuchi K., Rohlmann A., Sudhof T.C., Missler M. Deletion of alpha-neurexins does not cause a major impairment of axonal pathfinding or synapse formation. J. Comp. Neurol. 2007, 502(2):261-274.
7. Glessner J.T., Hakonarson H. Common variants in polygenic schizophrenia. Genome Biol. 2009, 10(9):236. (Epub 2009 September 29).
8. Ikeda M., Aleksic B., Kirov G., Kinoshita Y., Yamanouchi Y., Kitajima T., Kawashima K., Okochi T., Kishi T., Zaharieva I., Owen M.J., O'Donovan M.C., Ozaki N., Iwata N. Copy number variation in schizophrenia in the Japanese population. Biol. Psychiatry 2009.
9. Jeong J.H., Jin J.S., Kim H.N., Kang S.M., Liu J.C., Lengner C.J., Otto F., Mundlos S., Stein J.L., van Wijnen A.J., Lian J.B., Stein G.S., Choi J.Y. Expression of Runx2 transcription factor in non-skeletal tissues, sperm and brain. J. Cell. Physiol. 2008, 217(2):511-517.
10. Kang Y., Zhang X., Dobie F., Wu H., Craig A.M. Induction of GABAergic postsynaptic differentiation by alpha-neurexins. J. Biol. Chem. 2008, 283(4):2323-2334.
11. Kim H.G., Kishikawa S., Higgins A.W., Seong I.S., Donovan D.J., Shen Y., Lally E., Weiss L.A., Najm J., Kutsche K., Descartes M., Holt L., Braddock S., Troxell R., Kaplan L., Volkmar F., Klin A., Tsatsanis K., Harris D.J., Noens I., Pauls D.L., Daly M.J., MacDonald M.E., Morton C.C., Quade B.J., Gusella J.F. Disruption of neurexin 1 associated with autism spectrum disorder. Am. J. Hum. Genet. 2008, 82(1):199-207.
12. Kirov G., Gumus D., Chen W., Norton N., Georgieva L., Sari M., O'Donovan M.C., Erdogan F., Owen M.J., Ropers H.H., Ullmann R. Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia. Hum. Mol. Genet. 2008, 17(3):458-465.
13. Kralovicova J., Vorechovsky I. Position-dependent repression and promotion of DQB1 intron 3 splicing by GGGG motifs. J. Immunol. 2006, 176(4):2381-2388.
14. Lachman H.M., Fann C.S., Bartzis M., Evgrafov O.V., Rosenthal R.N., Nunes E.V., Miner C., Santana M., Gaffney J., Riddick A., Hsu C.L., Knowles J.A. Genomewide suggestive linkage of opioid dependence to chromosome 14q. Hum. Mol. Genet. 2007, 16(11):1327-1334.
15. Lew J.M., Fei Y.L., Aleck K., Blencowe B.J., Weksberg R., Sadowski P.D. CDKN1C mutation in Wiedemann-Beck with syndrome patients reduces RNA splicing efficiency and identifies a splicing enhancer. Am. J. Med. Genet. A 2004, 127A(3):268-276.
16. Lise M.F., El-Husseini A. The neuroligin and neurexin families: from structure to function at the synapse. Cell. Mol. Life Sci. 2006, 63(16):1833-1849.
17. Liu Q.R., Drgon T., Johnson C., Walther D., Hess J., Uhl G.R. Addiction molecular genetics: 639,401 SNP whole genome association identifies many " cell adhesion" genes. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2006, 141(8):918-925.
18. Ma K., Zheng S., Zuo Z. The transcription factor regulatory factor X1 increases the expression of neuronal glutamate transporter type 3. J. Biol. Chem. 2006, 281(30):21250-21255.
19. Malaterre J., Mantamadiotis T., Dworkin S., Lightowler S., Yang Q., Ransome M.I., Turnley A.M., Nichols N.R., Emambokus J., Frampton R.G. Ramsay, c-Myb is required for neural progenitor cell proliferation and maintenance of the neural stem cell niche in adult brain. Stem Cells 2008, 26(1):173-181.
20. Marshall C.R., Noor A., Vincent J.B., Lionel A.C., Feuk L., Skaug J., Shago M., Moessner R., Pinto D., Ren Y., Thiruvahindrapduram B., Fiebig A., Schreiber S., Friedman J., Ketelaars C.E., Vos Y.J., Ficicioglu C., Kirkpatrick S., Nicolson R., Sloman L., Summers A., Gibbons C.A., Teebi A., Chitayat D., Weksberg R., Thompson A., Vardy C., Crosbie V., Luscombe S., Baatjes R., Zwaigenbaum L., Roberts W., Fernandez B., Szatmari P., Scherer S.W. Structural variation of chromosomes in autism spectrum disorder. Am. J. Hum. Genet. 2008, 82(2):477-488.
21. McCarthy E.M., Phillips J.A. Characterization of an intron splice enhancer that regulates alternative splicing of human GH pre-Mrna. Hum. Mol. Genet. 1998, 7(9):1491-1496.
22. 2+ channels to synaptic vesicle exocytosis. Nature 2003, 423(6943):939-948.
23. Need A.C., Ge D., Weale M.E., Maia J., Feng S., Heinzen E.L., Shianna K.V., Yoon W., Kasperaviciūte D., Gennarelli M., Strittmatter W.J., Bonvicini C., Rossi G., Jayathilake K., Cola P.A., McEvoy J.P., Keefe R.S., Fisher E.M., St Jean P.L., Giegling I., Hartmann A.M., Möller H.J., Ruppert A., Fraser G., Crombie C., Middleton L.T., St Clair D., Roses A.D., Muglia P., Francks C., Rujescu D., Meltzer H.Y., Goldstein D.B. A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genet. 2009, 5(2):e1000373.
24. Nussbaum J., Xu Q., Payne T.J., Ma J.Z., Huang W., Gelernter J., Li M.D. Significant association of the neurexin 1 gene (NRXN1) with nicotine dependence in European and African American smokers. Hum. Mol. Genet. 2008.
25. Owen M.J., Williams H.J., O'Donovan M.C. Schizophrenia genetics: advancing on two fronts. Curr. Opin. Genet. Dev. 2009, 19(3):266-270.
26. Pedrosa E., Kaushik S., Lachman H.M. ChIP-chip analysis of neurexins and other candidate genes for addiction and neuropsychiatric disorders. J. Neurogenet. 2009, (December 8). (Epub ahead of print).
27. Rujescu D., Ingason A., Cichon S., Pietiläinen O.P., Barnes M.R., Toulopoulou T., Picchioni M., Vassos E., Ettinger U., Bramon E., Murray R., Ruggeri M., Tosato S., Bonetto C., Steinberg S., Sigurdsson E., Sigmundsson T., Petursson H., Gylfason A., Olason P.I., Hardarsson G., Jonsdottir G.A., Gustafsson O., Fossdal R., Giegling I., Möller H.J., Hartmann A.M., Hoffmann P., Crombie C., Fraser G., Walker N., Lonnqvist J., Suvisaari J., Tuulio-Henriksson A., Djurovic S., Melle I., Andreassen O.A., Hansen T., Werge T., Kiemeney L.A., Franke B., Veltman J., Buizer-Voskamp J.E., GROUP Investigators, Sabatti C., Ophoff R.A., Rietschel M., Nöthen M.M., Stefansson K., Peltonen L., St Clair D., Stefansson H., Collier D.A. Disruption of the neurexin 1 gene is associated with schizophrenia. Hum. Mol. Genet. 2009, 18(5):988-996.
28. Vrijenhoek T., Buizer-Voskamp J.E., van der Stelt I., Strengman E., Genetic Risk and Outcome in Psychosis (GROUP) Consortium, Sabatti C., Geurts van Kessel A., Brunner H.G., Ophoff R.A., Veltman J.A. Recurrent CNVs disrupt three candidate genes in schizophrenia patients. Am. J. Hum. Genet. 2008, 83(4):504-510.
29. Wang L.H., Chen J.Y., Liou Y.J., Wang Y.C., Lai I.C., Liao D.L., Chen C.H. Association of missense variants of the PRKC, apoptosis, WT1, regulator (PAWR) gene with schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32(3):870-875.
30. Yan J., Noltner K., Feng J., Li W., Schroer R., Skinner C., Zeng W., Schwartz C.E., Sommer S.S. Neurexin 1alpha structural variants associated with autism. Neurosci. Lett. 2008, 438(3):368-370.